A new hormone therapy should enter through a defined service-line review — product, prescriber, controlled-substance status, pharmacy, evaluation, staffing, documentation.
Clinical governance reviewed by Armando A Falcon, MD (FL ME 84789) · Florida regulatory framework reviewed August 2026.
A new hormone therapy should enter the practice through a defined service-line review — not because a vendor introduced a new product or patients started asking for it. Review the clinical purpose, prescriber, product, pharmacy, controlled-substance status, staffing, documentation, and monitoring model before it reaches the menu.
What exact hormone/product is proposed and its intended use? Is it commercially available or compounded? Is it controlled? Who prescribes, and who administers or performs the procedure? What pharmacy/source is used? What patient evaluation is required, and what documentation and monitoring/escalation change? Does it need new supplies/equipment, or affect insurance, malpractice, or AHCA structure?
Treat a new hormone product as a clinical service-line decision, not a menu update. See Add a Service Line to structure it.
Disclaimer — B2B clinical-governance & compliance education only. This content is general business, clinical-governance, and compliance information for healthcare practices. It does not create a physician-patient relationship, provide patient-specific medical advice or prescribing authority, or constitute legal advice. Requirements vary by ownership, services offered, provider credentials, payer model, facility type, and whether a practice is licensed or exempt — clinics remain responsible for independently verifying the current laws, rules, and professional requirements that apply to their structure and services before implementation.
Florida Statutes §893.03 — Controlled-substance schedules
Florida Statutes Chapter 465 — Pharmacy Act (compounding & dispensing)
Florida Statutes Chapter 458 — Medical Practice Act
Hormone Therapy (HRT · TRT · BHRT) — medical director services
All Florida medical-director resources
Medical director services across selected Central, South, and Gulf Coast Florida markets — Miami & Fort Lauderdale, Palm Beach County, Orlando, Tampa Bay, Sarasota & Bradenton, Fort Myers & Naples. See areas we serve. Clinic acceptance and physician availability are confirmed for each location.
Under the medical direction of Armando A Falcon, MD (FL ME 84789). Serving approved Central, South, and Gulf Coast Florida markets; clinic acceptance and physician availability confirmed individually. Call or WhatsApp +1 (305) 877-7507.